MYH10

Chr 17

myosin heavy chain 10

Also known as: NMMHC-IIB, NMMHCB

This protein is a cellular myosin that functions in cytokinesis, cell shape maintenance, and cytoskeletal reorganization during cell spreading. Mutations cause autosomal dominant May-Hegglin anomaly and related macrothrombocytopenia syndromes characterized by bleeding disorders due to large platelets and low platelet counts. The gene is highly constrained against loss-of-function variants, indicating that such mutations are likely to be severe.

OMIMResearchSummary from UniProt
DNmechanismLOEUF 0.17
Clinical SummaryMYH10
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder with or without congenital anomalies · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
24 unique Pathogenic / Likely Pathogenic· 282 VUS of 381 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint
0.17LOEUF
pLI 1.000
Z-score 8.96
OE 0.10 (0.070.17)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
5.01Z-score
OE missense 0.58 (0.550.62)
671 obs / 1148.4 exp
Constrained

Extremely missense-constrained (top ~0.01%)

Observed / Expected Ratios
LoF OE0.10 (0.070.17)
00.351.4
Missense OE0.58 (0.550.62)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 12 / 116.2Missense obs/exp: 671 / 1148.4Syn Z: 1.19
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateMYH10-related multiple congenital anomaliesDNAD
DN
0.5967th %ile
GOF
0.4283th %ile
LOF
0.57top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF21% of P/LP variants are LoF · LOEUF 0.17
DN1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNMYH10 variant overexpression produced a dominant-negative effect on ciliary length.PMID:35980381

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

381 submitted variants in ClinVar

Classification Summary

Pathogenic15
Likely Pathogenic9
VUS282
Likely Benign26
Benign16
Conflicting1
15
Pathogenic
9
Likely Pathogenic
282
VUS
26
Likely Benign
16
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
2
11
0
15
Likely Pathogenic
3
6
0
0
9
VUS
19
255
7
1
282
Likely Benign
0
5
8
13
26
Benign
0
3
5
8
16
Conflicting
1
Total242713122349

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MYH10 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →